Table 2.
Baseline demographic and clinical characteristics of feasibility trial participants
| Intervention (n = 21) |
Control (n = 12) |
All (n = 33) |
|
|---|---|---|---|
| Mean (SD) | |||
| Age (years) | 57.4 (10.2) | 60.1 (7.5) | 58.3 (10) |
| Body mass index (kg/m2) | 29.2 (5.3) | 27.6 (5.6) | 28.6 (5.4) |
| Index of multiple deprivation | 1212.8 (539.4) | 1023.6 (601.5) | 1143.9 (552.8) |
| Time from surgery to radiotherapy (days) | 61.5 (12.2) | 61.0 (16.7) | 61.3 (13.7) |
| Frequency (% of group) | |||
| Work | |||
|
Retired/housewife Changed/postponed Continued work |
5 (24) 14 (66) 2 (10) |
7 (58) 4 (34) 1 (8) |
12 (36) 18 (55) 3 (9) |
| Diagnosis | |||
|
Carcinoma in situ Invasive ductal cancer Invasive lobular cancer |
2 (10) 15 (71) 4 (19) |
1 (8) 8 (67) 3 (25) |
3 (9) 23 (70) 7 (21) |
| Tumour/Node/Metastasis stage group | |||
|
0 I II III |
2 (10) 6 (29) 10 (48) 3 (13) |
1 (8) 5 (41) 5 (42) 1 (8) |
3 (9) 11 (33) 15 (46) 4 (12) |
| Laterality | |||
|
Right Left |
13 (62) 8 (38) |
5 (42) 7 (58) |
18 (54) 15 (46) |
| Grade | |||
|
1 2 3 |
1 (5) 9 (43) 11 (52) |
2 (17) 6 (50) 4 (33) |
3 (9) 15 (45.5) 15 (45.5) |
| Surgical procedure | |||
|
Wide local excision Mastectomy |
19 (91) 2 (9) |
11 (92) 1 (8) |
29 (91) 3 (9) |
| Chemotherapy | |||
|
Yes No |
14 (67) 7 (33) |
5 (42) 7 (58) |
19 (59.4) 13 (40.6) |
| Travel mode for treatment | |||
|
Self Hospital transport |
21 (100) 0 |
12 (100) 0 |
33 (100) 0 |
| Breast boost 10 Gy/5#/1 week | 1 (5) | 1 (8) | 1 (6) |
| 40 Gy/15#/3 weeks to SCF | 1 (5) | 0 | 1 (5) |